Lv1
40 积分 2021-09-25 加入
Obinutuzumab‐related adverse events: A systematic review and meta‐analysis
3个月前
已完结
Improvements in Lymphoma Symptoms and Health-Related Quality of Life in Patients with Relapsed or Refractory Large B-Cell Lymphoma Treated with Subcutaneous Epcoritamab (EPCORE NHL-1)
3个月前
已关闭
Emerging biomarkers for CD3×CD20 bispecific antibodies in lymphoma
8个月前
已完结
Real-World Effectiveness and Safety Outcomes of Acalabrutinib Treatment in Patients with Relapsed/Refractory Mantle Cell Lymphoma
1年前
已关闭
An evaluation of odronextamab for the treatment of multiple subtypes of relapsed/refractory B-cell non-hodgkin lymphoma
1年前
已完结
皖公网安备34019202002308
